性能参数

产品名称

Pelcitoclax

规格

1 mg 5 mg 10 mg 25 mg 50 mg

货号

GOY-Y3014

 含量

>98.00%

CAS

1619923-36-2

别名

N/A

化学名

N/A

分子式

C57H66ClF4N6O11PS4

分子量

分子量 1281.85

溶解度

N/A

储存条件

Store at -20°C

General tips

用途

仅供科研

价格

电询

详细内容

Pelcitoclax (APG-1252) is a potent Bcl-2/Bcl-xl inhibitor with antineoplastic and pro-apoptotic effects[1].

APG-1252 changes to the reactive metabolite named APG-1252-M1, which has remarkable antitumor effects in acute myeloid leukemia[1].

Pelcitoclax (APG-1252; 25-100 mg/kg; i.v.; once a day; for 10days) treatment inhibits xenograft tumor growth more obviously than the other groups[1].

[1]. Hanjie Yi, et al. Bcl-2/Bcl-xl inhibitor APG-1252-M1 is a promising therapeutic strategy for gastric carcinoma. Cancer Med. 2020 Jun;9(12):4197-4206.

.

N,N'-羰基二咪唑 99%  高氯酸铒(III),六水 50% 水溶液,试剂级

2-氯-1,3-二甲基咪唑鎓四氟硼酸盐 98%  金属铒 锭, 99.9% metals basis

N,N'-羰基二(1,2,4-三氮唑)  96%  三氧化二铁 CP，Fe 68.9-70.1%

氯代二碳鎓六氟磷酸盐 98%  三氧化二铁 AR，69.8-70.1%

氯代三吡咯烷基鏻六氟磷酸盐 98%  三氧化二铁 SP

多肽试剂TCTU 98%  三氧化二铁 99.99% metals basis

Ropivacaine HCl10mM (in 1mL DMSO) 50mg>98.00%Cas No. 98717-15-8C17H26N2O.HCl

Ro 5110mg 50mg>98.00%Cas No. 1050670-85-3C17H23IN4O4

Saclofen10mg 50mg>98.00%Cas No. 125464-42-8C9H12ClNO3S

S-8510 phosphate (SB-737552 phosphate)250mg 500mg>98.00%Cas No. 151466-23-8C12H13N4O6P

Ru360100μg 500μg>98.00%Cas No. N/AC2H26Cl3N8O5Ru2 3-

SDZ 220-581 hydrochloride10mg 50mg>98.00%Cas No. 179411-93-9C16H18Cl2NO5P

SDZ 220-58110mg 50mg>98.00%Cas No. 174575-17-8C16H17ClNO5P